Huge congratulations to Chuqi for being honored with the Faculty of Science PhD Conference Award (FPCA), designed to encourage PhDs to present their research work at conferences! Your dedication and hard work have truly paid off. We're incredibly proud of your achievement! 🎉👏

The Bhatt lab participated in Frontiers in Cancer Science 2024. Beyond gaining new insights on the emerging cancer researches, Ahmed, Aarthi, Chuqi, Shaista and Hoshea also showcased their work through poster presentations!

​

A special congratulations to Shaista for securing 3rd prize in the Poster Presenters category at FCS 2024!

The lab bids a heartfelt farewell to Fangqi, Jason, and Eunicia, who will be leaving in November 2024.

​

Fangqi, who joined us as a Postdoctoral Fellow in November 2022, made significant contributions to the TP53 project and played a vital role in mentoring many lab members, which greatly advanced our projects.

Jason, who served as our Laboratory Executive since September 2023, played a crucial role in maintaining our lab's functions, ensuring smooth operations.

Eunicia, who became a Research Assistant in March 2024, significantly propelled our projects through her dedicated efforts.

​

We wish them all the best in their future endeavors and thank them for their invaluable contributions!

Chuqi's project was selected to be funded by Paris-NUS PhD mobility grant. Supported through this funding Chuqi will visit University of Paris Cite at INSERM to our collaborator Alexander Puissant lab to continue his studies on targeting TP53 mutant AML. 

​​

Well done Chuqi and we look forward to your results on tackling this most aggressive leukemia through your novel ideas. 

​

Bhatt lab is grateful to NUS-UParis funding program for receiving their 2nd fudning to study immune evasion mechanisms for TP53 mutant AML. This project is led by Chuqi and Jordan in the lab. 

The lab also welcomed 3 new masters students into the lab, completing under the supervision of Dr Shruti.

​

Soraya Mojdehi is a student under the Masters of Science (Pharmaceutical Science and Technology) with the Department of Pharmacy and Pharmaceutical Sciences.

​

Miao Shengyu and Li Yun are both students undergoing their Masters in the Department of Biological Sciences.

The new Academic Year had just begun, and with a new year, we welcomed many new members to the lab.

​

We welcome Ankit Jana to our lab - Ankit is a Year 2 PhD Student with the Department of Biological Sciences, and he will be undertaking this project co-supervised by Dr Shruti.

​

Read more about him on our Team Page!

We are pleased to announced that Chuqi has recently been awarded the Azenta SPARK Grant 2024!

The Azenta Supporting Progressive Advancement in Research and nowledge (SPARK) Grant 2024 is a grant initiative designed to support the research efforts of Ph.D students and up-and-coming researchers, especially in the field of immunology, food and agriculture. This grant is a victory nonetheless, as it will aid us in our work.

​

Congratulations Chuqi, and Well Done!

The lab welcomes Cheryl, our newest member who joined us on 1 July 2024. She will be completing her Final-Year Project with the lab.

The lab received the Leukemia Foundation New Investigator Research Grant this month!

​

The grant is a 2-year grant meant support new and upcoming researchers in the domain of Leukemia. We believe that our project on "Identifying Therapeutic Strategies for TP53-mutated acute myeloid leukemia" will be highly supported with this grant. 

​

We thank the Leukemia Research Foundation for Recognizing our Efforts!

The lab bade its goodbye to Nishtha, who will be leaving the lab in June 2024.

She will be leaving to do her PhD in Duke-NUS Medical School.

Nishtha had faithfully served the lab as a Research Assistant since May 2023, and her own efforts helped to propel the lab's projects greatly. 

We wish her all the best in her future endeavours!

The month would continue to bring much achievements to celebrate. Soomin, our undergraduate, was recently awarded the Undergraduate Research Opportunities Programme in Science Research Experience (UROPS REx) Grant, and she is currently at the Dana-Farber Cancer Center in Boston for the next few months.

The EMBO YIP Cancer Sectorial Meeting was held from May 15-17, 2024 in Lednice, Czech Republic. Chuqi had his chance to present this topic at the meeting, an annual gathering of cancer researchers to update themselves in their respective domains.

​

Well done, Chuqi on your presentation!

The month of May was exceptionally productive and busy for the lab, here's what we have been up to:

​

The Forbeck Forum for Non-genetic Drug Tolerance Mechanisms was held from May 12-15, 2024 in Milan, Italy. Dr Shruti was one of the chairs of the meeting, which aimed to bring together global researchers of cancer persisters - a relatively newer field of study. Karan had the chance to present his topic at the meeting.

​

Well Done, Karan, on your work and presentaton!

The Department recently held a symposium to showcase the Final Year Projects (FYP) of their undergraduate students on 12 April 2024. One of our members, Mi Yang, had recently completed his FYP project, and had his poster presented as part of the symposium.

​

The lab is also pleased to hear that he had also just accepted an offer to begin his PhD Programme at the Yong Loo Lin School of Medicine.

​

Congratulations and Well Done! Thank you for your work throughout this project, and all the best to you for your future endeavours!

The Lab welcomed two new members this year.

​

Jordan joined us as a Graduate Tutor and PhD Student in January 2024. He was previously undergoing his pre-registration year as a pharmacist in a local hospital.

​

Eunicia joined us as a Research Assistant in March 2024. was previously pursuing her undergraduate studies in Psychology at the National University of Singapore.

​

Welcome to the family!

Our new collaborative work with the Letai lab explains the biology behind multi-drug resistance in relapsed cancer cells. A key finding was that a reduction in mitochondrial apoptotic priming accompanies acquired resistance to a wide variety of targeted agents, suggesting that it is a mechanism for the acquired multi-resistance seen in the clinic. Congratulations to Karan (first co-author), Chuqi, Ahmed, Shaishta, Hoshea and other past Bhatt lab members on their incredible/fantastic work!

​

Read about this as well as other publications here.

Press release related to our work:

Dana-Farber Cancer Institute (5 March 2024)

American Association for Cancer Research (18 March 2024)

Faculty of Science, National University of Singapore (19 March 2024)

NUSnews, National University of Singapore (5 April 2024)

Shruti was recently invited as a mentor faculty for the 2nd ASH Clinical Research Training Institute in Asia Pacific which was held on 13-14 February 2024 in Sydney Australia. The workshop, spanning 2 days, was aimed at helping new, up-and-coming researchers and faculty in the field of Haematology based in the Asia-Pacific region build up and strengthen their clinical research skills, as well as to develop themselves into leaders in their respective domains of research. The event ended with the trainee day on 15 February 2024.